BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

BioNews
Biotechnology, Pharmaceutical and Life Science News
search help

Search Results

Documents 1-25 out of 35 found
  Current Search:  ser: 35, gen: 273     

HTML
57%
Life Sciences: Karolinska Institut details research in life sciences
Today's Medical & Research News Life Sciences Karolinska Institut details research in life sciences February 7th, 2010 Printer-Friendly Version City:Stockholm Country:Sweden Life Sciences Cancer Oncology Apoptosis Kinase Enzymes Current study results from...
NewsRX:  Feb 7 2010 5:03AM
Matching: ser
Find similar documents
HTML
57%
Scientists at New England Biolabs, Inc. target life sciences
Current study results from the report, 'Splicing of the mycobacteriophage Bethlehem DnaB intein: identification of a new mechanistic class of inteins that contain an obligate block F nucleophile,' have been published.

'Inteins are single turnover enzymes that...

NewsRX:  Feb 5 2010 1:45PM
Matching: ser
Find similar documents
HTML
57%
Life Sciences: Scientists at New England Biolabs, Inc. target life sciences
Today's Medical & Research News Life Sciences Scientists at New England Biolabs, Inc.

target life sciences February 5th, 2010 Printer-Friendly Version City:Ipswich State:Massachusetts Country:United States Life Sciences Protein Precursor Proteomics...

NewsRX:  Feb 5 2010 5:15AM
Matching: ser
Find similar documents
HTML
57%
IEA Awarded Contract by the U.S. Nuclear Regulatory Commission (NRC)
Companies mentioned in this article: Ian, Evan & Alexander Corporation NATIONAL HARBOR, Md., Feb.

4 /PRNewswire/ -- Ian, Evan & Alexander Corporation (IEA) has been awarded a contract by the U.S.

Nuclear Regulatory Commission (NRC).

Under this...

Freshnews.com:  Feb 4 2010 9:51PM
Matching: ser
Find similar documents
HTML
57%
Paloma Pharmaceuticals recibe la aprobacin para realizar ensayos clnicos en Fase I
- La FDA acepta la IND para comenzar con la administracin intravitreal y subconjuntiva de Palomid 529 en pacientes con degeneracin macular relacionada con la edad - JAMAICA PLAIN, Massachusetts, February 4 /PRNewswire/ -- Paloma Pharmaceuticals, Inc.

ha...

Sys-Con Media:  Feb 4 2010 8:43PM
Matching: ser
Find similar documents
HTML
57%
Glaxo 'regala' curas potenciales de malaria
PUBLICIDAD Andrew Witty, presidente ejecutivo de la compaa, anunci en Nueva York que la empresa dar acceso gratuito a 13.500 molculas que ha identificado como tratamientos potenciales contra el parsito que causa la enfermedad.

El objetivo es que otros...

New York Bilingual News:  Feb 2 2010 9:10PM
Matching: ser
Find similar documents
HTML
57%
Stem Cells from Amniocentesis: Biocell Center Partners With Innovative Medical Solutions to Distribute Its Ser
MEDFORD, Mass., Feb.

1 /PRNewswire/ -- Preservation of amniotic fluid stem cells is an innovative technology that recently became available to expecting mothers in the United States with Biocell Center having launched its pioneering service here following its...

TickerTech.com:  Feb 1 2010 4:42PM
Matching: ser
Find similar documents
HTML
57%
Beneficial effect of the oligomerized polyphenol oligonol on high glucose-induced changes in eNOS phosphorylation and dephosphorylation in endothelial cells
Background and purpose: Hyperglycaemia is known to reduce nitric oxide (NO) bioavailability by modulating endothelial NO synthase (eNOS) activity, and polyphenols are believed to have cardiovascular benefit.

One possible mechanism could be through interaction...

British Journal of Pharmacology:  Jan 30 2010 10:38AM
Matching: ser
Find similar documents
HTML
57%
Synomics Pharma And Bioscience Laboratories Announce Partnership To Provide Topical Clinical Phase 1 Study Ser
Synomics Pharmaand BioScience Laboratories, Inc.

announced a formal partnership to provide fully integrated topical clinical phase 1 study services for trials in healthy human subjects, providing drug developers with a single source for outsourcing clinical...

American Pharmaceutical Outsourcing:  Jan 30 2010 7:29AM
Matching: ser
Find similar documents
HTML
57%
Serenic Reports Strong Third Quarter for Three Months Ended November 30, 2009
Serenic Corporation (the 'Company' or 'Serenic') (TSX VENTURE: SER), an international software developer specializing in integrated financial management and HCM solutions for Non-Profit organizations, government agencies, and Microsoft Dynamics NAV users,...
Genetic Engineering News:  Jan 28 2010 1:19AM
Matching: ser
Find similar documents
HTML
57%
Surface Chemistry Experts Rely on Zetasizer Nano in Ground-Breaking Nanoparticles for Cancer ...
: Malvern, UK: Sandra Whaley Bishnoi, Assistant Professor of Chemistry at the Illinois Institute of Technology, has selected the Zetasizer Nano ZS from Malvern Instruments to meet the specific particle sizing and zeta potential measurement needs of her research...
ThomasNet:  Jan 28 2010 2:16PM
Matching: ser
Find similar documents
HTML
57%
Surface-enhanced Raman spectroscopy for facile DNA detection using gold nanoparticle aggregates formed via pho
The home of high impact research in analytical, bioanalytical and detection science.

Article citation: Nguyen T.

Thuy, Analyst, 2010, DOI: 10.1039/b919969a Nguyen T.

Thuy, Ryoko Yokogawa, Yoshinaga Yoshimura, Kenzo Fujimoto, Mikio Koyano and Shinya...

RSC:  Jan 23 2010 5:29PM
Matching: ser
Find similar documents
HTML
57%
Malvern Instruments: Surface Chemistry Experts Rely On Zetasizer Nano In Ground-Breaking Nanoparticles For Can
: Malvern, UK: Sandra Whaley Bishnoi, Assistant Professor of Chemistry at the Illinois Institute of Technology, has selected the Zetasizer Nano ZS from Malvern Instruments to meet the specific particle sizing and zeta potential measurement needs of her research...
BioSpace:  Jan 22 2010 6:43PM
Matching: ser
Find similar documents
HTML
57%
Surface Chemistry Experts Rely On Zetasizer Nano In Ground-Breaking Nanoparticles For Cancer Research
Sandra Whaley Bishnoi, Assistant Professor of Chemistry at the Illinois Institute of Technology, has selected the Zetasizer Nano ZS from Malvern Instruments to meet the specific particle sizing and zeta potential measurement needs of her research team.

Dr...

Bioresearch Online:  Jan 22 2010 9:53AM
Matching: ser
Find similar documents
HTML
57%
Surface Chemistry Experts Rely On Zetasizer Nano In Ground-Breaking Nanoparticles For Cancer Research
Sandra Whaley Bishnoi, Assistant Professor of Chemistry at the Illinois Institute of Technology, has selected the Zetasizer Nano ZS from Malvern Instruments to meet the specific particle sizing and zeta potential measurement needs of her research team.

Dr...

Pharmaceutical Online:  Jan 22 2010 8:49AM
Matching: ser
Find similar documents
HTML
57%
Surface chemistry experts rely on Zetasizer Nano in ground-breaking nanoparticles for cancer research
: Malvern, UK: Sandra Whaley Bishnoi, Assistant Professor of Chemistry at the Illinois Institute of Technology, has selected the Zetasizer Nano ZS from Malvern Instruments to meet the specific particle sizing and zeta potential measurement needs of her research...
BioPortfolio:  Jan 20 2010 8:48PM
Matching: ser
Find similar documents
HTML
57%
Malvern Particle Sizer Used for Ground-Breaking Nanoparticle Cancer Research
Sandra Whaley Bishnoi, Assistant Professor of Chemistry at the Illinois Institute of Technology, has selected the Zetasizer Nano ZS from Malvern Instruments to meet the specific particle sizing and zeta potential measurement needs of her research team.

Dr...

Research & Development:  Jan 20 2010 6:03PM
Matching: ser
Find similar documents
HTML
57%
Malvern Zetasizer Selected for Ground-Breaking Cancer research
Sandra Whaley Bishnoi, Assistant Professor of Chemistry at the Illinois Institute of Technology, has selected the Zetasizer Nano ZS from Malvern Instruments to meet the specific particle sizing and zeta potential measurement needs of her research team.

Dr...

Azonano:  Jan 20 2010 4:27PM
Matching: ser
Find similar documents
HTML
57%
PCI Biotech Holding : PCI Biotech rapporterer om ...
PCI Biotech rapporterer om vellykket fullfring av andre dosegruppe i fase I/II studien med Amphinex.

Kraftig effekt er observert p alle behandlede kreftsvulster Oslo, 19.januar 2010 - PCI Biotech melder i dag at selskapet har fullfrt behandlingen av andre...

Investegate:  Jan 19 2010 7:43AM
Matching: ser
Find similar documents
HTML
57%
Research Leads To A Novel Optofluidics Platform Of Long Optical Path For Robust Chem/bio Sensing, Process Moni
A research paper that has potential implications for homeland defense, work place safety, and health care has been published in the Journal of Advanced Materials (volume, issue, 2010) and reported by materialsviews.com.

The latter is a materials news service...

Medical News Today:  Jan 18 2010 4:20PM
Matching: ser
Find similar documents
HTML
57%
Four Leading Pharmaceutical Companies Select Cegedim Dendrites Customer Master Data Management Solution
Cegedim Dendrite today announced that four prominent Life Sciences companies have contracted for its Customer Master Data Management solution, Nucleus as a Ser Four Leading Pharmaceutical Companies Select Cegedim Dendrites Customer Master Data Management...
Financial 24:  Jan 18 2010 11:46PM
Matching: ser
Find similar documents
HTML
57%
Sword Diagnostics launches Raman detection system for ultrasensitive immunoassays
Sword Dagnostcs annonced today the lanch of ts propretary Raman detecton system for ltrasenstve mmnoassays.

The system provdes researchers wth greater senstvty whch enales more accrate testng of low andance markers.

These ncreases n performance cold ad...

News-Medical.Net:  Jan 18 2010 7:39AM
Matching: ser
Find similar documents
HTML
57%
Stevens earns publication spot in top-rated Journal of Advanced Materials
Posted In: Life Sciences HOBOKEN, N.J.

A research paper that has potential implications for homeland defense, work place safety, and health care has been published in the Journal of Advanced Materials (volume, issue, 2010) and reported by materialsviews.com....

Research & Development:  Jan 15 2010 8:50PM
Matching: ser
Find similar documents
HTML
57%
Fitch Rates CentraCare (Minnesota) Ser 2010 Revs 'A'; Affirms Outstanding; Outlook Stable
Fitch Ratings assigns an 'A' rating to the following City of St.

Fitch Rates CentraCare (Minnesota) Ser 2010 Revs 'A'; Affirms Outstanding; Outlook Stable.

Individual.com:  Jan 14 2010 4:26PM
Matching: ser
Find similar documents
HTML
57%
Synomics Pharma and Bioscience Laboratories Announce Partnership to Provide Topical Clinical Phase 1 Study Ser
Synomics Pharma and BioScience Laboratories, Inc.

announced a formal partnership to provide fully integrated topical clinical phase 1 study services for trials in healthy human subjects, providing drug developers with a single source for outsourcing clinical...

Pharmacy Choice:  Jan 13 2010 8:31PM
Matching: ser
Find similar documents


 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.